Literature DB >> 15396

Myxofibrosarcoma. A study of 30 cases.

L Angervall, L G Kindblom, C Merck.   

Abstract

A series of 30 myxofibrosarcomas is described. These malignant soft tissue tumours are characterized by a mucoid and nodular appearance, a coarse plexiform capillary pattern, and they are mostly seen subcutaneously (26 out of 30) in the extremities (24 out of 30) and trunk (4 out of 30) elderly people. Histochemical studies, comprising staining with Alcian blue and toluidine blue at different pH's with and without preceding digestion with testicular hyaluronidase and with the Scott technique, indicated the presence of hyaluronic acid but not sulphated glycosaminoglycans as chondroitinsulphates. Myxofibrosarcoma is believed to belong to the general category of fibroblastic and histiocytic malignant soft tissue tumours. The median diameter of the tumours was 7 cm. They were divided into 4 grades according to cellularity, cell atypia and mitotic activity. The grade III and IV tumours showed pronounced atypia, often with the bi- and multinucleated giant tumour cells and occasionally with giant cells of Touton's type, suggesting a relationship to malignant fibroxanthoma. All of the patients were treated surgically and one received also pre- and post-operative irradiation. None of the 2 grade I myxofibrosarcomas recurred, while 2 out of 7 grade II tumours, 6 out of 10 grade III tumours, and 7 out of 11 grade IV tumours recurred once and up to 9 times. Metastasis appeared in 7 out of 30 patients; grade I tumours were not seen in any of these cases. By the time of follow-up after intervals ranging from 1 month up to 27 years, 14 patients had died; 6 of these had died post-operatively or of intercurrent disease. The differential diagnosis between myxofibrosarcoma and other myxoid soft tissue tumours is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 15396

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  42 in total

1.  Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.

Authors:  Ellen Heitzer; Sandra Sunitsch; Magdalena M Gilg; Birgit Lohberger; Beate Rinner; Karl Kashofer; Nicole Stündl; Peter Ulz; Joanna Szkandera; Andreas Leithner; Bernadette Liegl-Atzwanger
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  The ultrastructure of myxofibrosarcoma. A study of 11 cases.

Authors:  L G Kindblom; C Merck; L Angervall
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-02-09

3.  A case of myxofibrosarcoma of the maxilla with difficulty in preoperative diagnosis.

Authors:  Susumu Nakahara; Hirokazu Uemura; Tomoyuki Kurita; Motoyuki Suzuki; Takashi Fujii; Yasuhiko Tomita; Kunitoshi Yoshino
Journal:  Int J Clin Oncol       Date:  2011-08-10       Impact factor: 3.402

Review 4.  Adult paratesticular myxofibrosarcoma: report of a rare entity and review of the literature.

Authors:  Burak Ozkan; Mustafa Ozgüroğlu; Hamdi Ozkara; Haydar Durak; Zübeyr Talat
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

5.  Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches.

Authors:  Salvatore Romeo; Judith V M G Bovée; Herman M Kroon; Roberto Tirabosco; Cristina Natali; Lucia Zanatta; Raf Sciot; Fredrik Mertens; Nick Athanasou; Marco Alberghini; Karoly Szuhai; Pancras C W Hogendoorn; Angelo Paolo Dei Tos
Journal:  Virchows Arch       Date:  2012-09-22       Impact factor: 4.064

6.  Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.

Authors:  Ann Y Lee; Narasimhan P Agaram; Li-Xuan Qin; Deborah Kuk; Christina Curtin; Murray F Brennan; Samuel Singer
Journal:  Ann Surg Oncol       Date:  2016-01-12       Impact factor: 5.344

Review 7.  [Modern morphological diagnosis and current classification of soft tissue sarcomas].

Authors:  D Katenkamp; K Katenkamp
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

Review 8.  Running GAGs: myxoid matrix in tumor pathology revisited: what's in it for the pathologist?

Authors:  Stefan M Willems; Malgorzata Wiweger; J Frans Graadt van Roggen; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

9.  Primary myxofibrosarcoma of the parotid: case report.

Authors:  Xu Li; Xin Chen; Zhao-Hui Shi; Yang Chen; Jing Ye; Li Qiao; Jian-Hua Qiu
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

10.  Myxofibrosarcoma: prevalence and diagnostic value of the "tail sign" on magnetic resonance imaging.

Authors:  Robert A Lefkowitz; Jonathan Landa; Sinchun Hwang; Emily C Zabor; Chaya S Moskowitz; Narasimhan P Agaram; David M Panicek
Journal:  Skeletal Radiol       Date:  2013-01-15       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.